Aligos Therapeutics

📍 South San Francisco, United States🗓 Founded 2018👥 82 employees💰 Last funded Aug 2024
Biotechnology🌐 aligos.com
Website LinkedIn
Aligos is a biopharmaceutical company developing targeted therapeutics to address unmet medical needs in liver and viral diseases including MASH, CHB and COVID-19.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Aligos Therapeutics?
Aligos Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Aligos Therapeutics last raise funding?
The most recent investment in Aligos Therapeutics recorded on gritt.io was in August 2024.
When was Aligos Therapeutics founded?
Aligos Therapeutics was founded in 2018.
What industry is Aligos Therapeutics in?
Aligos Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Aligos Therapeutics based?
Aligos Therapeutics is headquartered in South San Francisco, United States.